Seven Eight Capital, LP Karyopharm Therapeutics Inc. Transaction History

Seven Eight Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$8.11 - $11.11 $377,926 - $517,726	-46,600 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$14.15 - $17.19 $438,650 - $532,890	-31,000 Reduced 39.95%	46,600 $721,000
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $1.1 Million - $1.53 Million	77,600 New	77,600 $1.13 Million
Q1 2020 May 14, 2020	SELL	$14.38 - $27.72 $349,434 - $673,596	-24,300 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$9.23 - $19.67 $224,289 - $477,981	24,300 New	24,300 $466,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.